Trustee

Anand is a co-founder and CEO of Bugworks, an Indo-USA-Australia biotech startup, working on tackling the massive problem posed by untreatable bacterial Superbugs which are implicated in hospital/community infections. Bugworks hopes to make a massive impact on humanity by addressing large unmet medical needs while making its products affordable and accessible to all. The company is supported by  investors from across the globe and is also actively supported by several governments for its work on Antibiotics and advanced solutions against Cancer.

Anand was previously co-founder and Managing Director at Cellworks a Bay area and Bangalore based company which is a pioneer in using modeling and simulation to support personalized cancer therapy area. Prior to the biotechnology experience, Anand was a professional in the semiconductor industry with about 15 years of global experience in designing high end Integrated Circuits.

Anand received his Bachelor's degree in Electronics and Communication from College of Engineering Guindy, Anna University, India (1986) and a MS & PhD in Electrical and Biomedical engineering from George Washington University in Washington D.C (1992). He won the distinguished alumnus award from Anna University in 2016.

Anand is a globally recognized key opinion leader in the Antimicrobial resistance (AMR)Industry and affiliations include, Member of Executive committee of India biotech association, Member of India advisory board of GARDp, Board member of AMR Industry Alliance, Advisory Board member of the India AMR Declaration trust, Member of AMR Working Group Bio USA, Co-founder of Indian Electronics and Semiconductor association (IESA), AMR member of G20 health development partnership And speaker in global platforms including the G20, WHO, UN, APIF-Japan etc. Anand is also co-founder and mentor to more than 4 biotech startups in the Bangalore life-science cluster including Biomoneta, Impres Health and Ignite Life sciences foundation.